Outcome | Studies, n | Patients, n | Random effects, OR (95% CI) | Fixed effects, OR (95% CI) | I2,%* | Heterogeneity P* |
---|---|---|---|---|---|---|
Overall death | ||||||
Overall | 5 | 1967 | 1.42 (0.50, 4.04) | 1.42 (0.50, 4.04) | 0 | 0.69 |
≤6 months measurement time | 4 | 1950 | 1.25 (0.42, 3.74) | 1.25 (0.42, 3.74) | 0 | 0.65 |
In-hospital mortality | ||||||
Overall | 5 | 1.55 (0.91, 2.61) | 1.35 (1.07, 1.70) | 52 | 0.08 | |
Adjusted OR | 3 | 3.35 (0.91, 12.30) | 3.46 (2.20, 5.44) | 83 | 0.003 | |
Disability (GOS) | ||||||
Overall | 9 | 754 | 2.38 (1.33, 4.26) | 2.38 (1.33, 4.26) | 0 | 0.99 |
≤6 months measurement time | 4 | 314 | 2.72 (1.16, 6.34) | 2.72 (1.16, 6.34) | 0 | 0.81 |
>6 months measurement time | 4 | 331 | 2.12 (0.93, 4.84) | 2.12 (0.93, 4.84) | 0 | 0.90 |
Asian races | 4 | 413 | 2.41 (1.19, 4.90) | 2.41 (1.19, 4.90) | 0 | 0.84 |
Western races | 5 | 341 | 2.32 (0.84, 6.39) | 2.32 (0.84, 6.39) | 0 | 0.92 |
Disability (mRS) | 2 | 262 | 2.83 (1.42, 5.63) | 2.83 (1.42, 5.63) | 0 | 0.81 |
0 | 0.72 | |||||
Complication | ||||||
Cerebral haemorrhage | 8 | 7419 | 1.96 (0.83, 4.64) | 1.44 (1.03, 2.02) | 63 | 0.01 |
Cerebral infarction | 12 | 7635 | 1.07 (0.69, 1.66) | 0.96 (0.74, 1,23) | 39 | 0.08 |
Neurological complication | 11 | 7661 | 1.94 (1.09-3.47) | 1.38 (1.12, 1.71) | 58 | 0.009 |
Cardiac complication | 6 | 7067 | 2.51 (1.15. 5.50) | 2.51 (1.15. 5.50) | 0 | 0.98 |